UBS lowered the firm’s price target on Intermex (IMXI) to $12 from $17 and keeps a Neutral rating on the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMXI:
- Hold Rating for International Money Express Amid Market Challenges and Strategic Uncertainty
- Intermex downgraded to Market Perform from Outperform at BMO Capital
- Intermex Reports Mixed First-Quarter 2025 Results
- Intermex reports Q1 adjusted EPS 35c, consensus 42c
- Intermex sees FY25 adjusted EPS $1.86-$2.02, consensus $2.17